GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
5.08M
SGMT
Price
$10.24
Change
+$0.04 (+0.39%)
Updated
Jul 25 closing price
Capitalization
329.68M
29 days until earnings call
Interact to see
Advertisement

GENFF vs SGMT

Header iconGENFF vs SGMT Comparison
Open Charts GENFF vs SGMTBanner chart's image
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$1K
Capitalization5.08M
Sagimet Biosciences
Price$10.24
Change+$0.04 (+0.39%)
Volume$1.17M
Capitalization329.68M
GENFF vs SGMT Comparison Chart in %
Loading...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GENFF vs. SGMT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENFF is a Hold and SGMT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (GENFF: $0.01 vs. SGMT: $10.24)
Brand notoriety: GENFF and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GENFF: 2% vs. SGMT: 60%
Market capitalization -- GENFF: $5.08M vs. SGMT: $329.68M
GENFF [@Biotechnology] is valued at $5.08M. SGMT’s [@Biotechnology] market capitalization is $329.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GENFF’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • GENFF’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than GENFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GENFF’s TA Score shows that 3 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • GENFF’s TA Score: 3 bullish, 3 bearish.
  • SGMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GENFF is a better buy in the short-term than SGMT.

Price Growth

GENFF (@Biotechnology) experienced а +33.00% price change this week, while SGMT (@Biotechnology) price change was +8.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

SGMT is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($330M) has a higher market cap than GENFF($5.08M). SGMT YTD gains are higher at: 127.556 vs. GENFF (-77.944).
GENFFSGMTGENFF / SGMT
Capitalization5.08M330M2%
EBITDAN/A-65.55M-
Gain YTD-77.944127.556-61%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A145M-
Total DebtN/A39K-
TECHNICAL ANALYSIS
Technical Analysis
GENFFSGMT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE1.460.12
+8.96%
VYNE Therapeutics
MFIC13.03N/A
N/A
MidCap Financial Investment Corp
GOLF82.17N/A
N/A
Acushnet Holdings Corp
FAST47.75-0.18
-0.38%
Fastenal Co
FDMT4.57-0.04
-0.87%
4D Molecular Therapeutics

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
TOVX - GENFF
25%
Poorly correlated
+1.24%
VRCA - GENFF
23%
Poorly correlated
-5.57%
SGMT - GENFF
10%
Poorly correlated
+0.39%
OCS - GENFF
6%
Poorly correlated
+0.34%
APGE - GENFF
3%
Poorly correlated
-1.97%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with TERN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+0.39%
TERN - SGMT
40%
Loosely correlated
N/A
CCCC - SGMT
40%
Loosely correlated
-1.31%
OCUL - SGMT
38%
Loosely correlated
+2.43%
CRBU - SGMT
38%
Loosely correlated
-3.80%
VRDN - SGMT
38%
Loosely correlated
-1.20%
More